Recombinant CD52 (Alemtuzumab Biosimilar) antibody

Catalog No. ABIN7487793

This Mammalian Cells Monoclonal antibody specifically detects CD52 (Alemtuzumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant CD52 (Alemtuzumab Biosimilar) antibody (ABIN7487793)

Target: CD52 (Alemtuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This CD52 (Alemtuzumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-CD52 (Alemtuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Alemtuzumab Biosimilar - Anti-CD52 mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD52 (Alemtuzumab Biosimilar)

Target: CD52 (Alemtuzumab Biosimilar)

Target Type: Biosimilar

Background: Campath-1H,LDP-03
Alemtuzumab is a recombinant humanized monoclonal antibody (Campath-1H), which targets the 21-28 kD cell surface glycoprotein CD52. The Campath-1H antibody is of isotype IgG1, with human variable framework and constant regions, and a complementarity determining region derived from a murine (rat) monoclonal antibody (Campath-1G).

CAS-No: 216503-57-0